The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung

NCT03595891 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 660

Last updated 2022-05-05

No results posted yet for this study

Summary

A study based on a chart review of participants that presented with a sudden blood clot in the lung

Conditions

  • Pulmonary Embolism (PE)
  • Pulmonary Thromboembolism

Interventions

OTHER

Non-Interventional

Non-Interventional

Sponsors & Collaborators

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-20
Primary Completion
2021-01-29
Completion
2021-01-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03595891 on ClinicalTrials.gov